Jiangxi Pingxiang People's Hospital, Department of Otorhinolaryngology Head and Neck Surgery, Pingxiang, China.
Jiangxi Pingxiang People's Hospital, Department of Otorhinolaryngology Head and Neck Surgery, Pingxiang, China.
Braz J Otorhinolaryngol. 2022 Nov-Dec;88 Suppl 4(Suppl 4):S108-S116. doi: 10.1016/j.bjorl.2022.06.005. Epub 2022 Jul 6.
This study aims to explore the effect and mechanism of miR-375 in Laryngeal Squamous Cell Carcinoma (LSCC) cell progression.
LSCC cells (LSC-1 and TU177) were transfected with miR-375-mimic, miR-375-inhibitor or miR-375-mimic+oe-CST1. The expression of miR-375, CST1, MMP-2, and MMP-9 was measured. The effect of miR-375-mimic, miR-375-inhibitor or miR-375-mimic+oe-CST1 on cell biological functions, including cell proliferation, migration, invasion, and apoptosis, was also assessed. The potential relationship between CST1 and miR-375 was predicted by Jefferson software and validated by dual luciferase reporter gene assay.
Downregulated miR-375 expression was found in LSCC cells. Overexpression of miR-375 inhibited the viability and migration and promoted apoptosis of LSCC cells. Jefferson database and dual luciferase reporter gene assay confirmed that miR-375 directly targeted CST1. Overexpression of CST1 could reverse the anti-cancer effect of miR-375 overexpression in LSCC cells.
Collected evidence showed that miR-375/CST1 axis was implicated in LSCC progression.
Level 3.
本研究旨在探讨 miR-375 在喉鳞状细胞癌(LSCC)细胞进展中的作用和机制。
转染 LSCC 细胞(LSC-1 和 TU177)miR-375-模拟物、miR-375-抑制剂或 miR-375-模拟物+过表达-CST1。测量 miR-375、CST1、MMP-2 和 MMP-9 的表达。还评估了 miR-375-模拟物、miR-375-抑制剂或 miR-375-模拟物+过表达-CST1 对细胞生物学功能的影响,包括细胞增殖、迁移、侵袭和凋亡。Jefferson 软件预测 CST1 和 miR-375 之间的潜在关系,并通过双荧光素酶报告基因检测进行验证。
在 LSCC 细胞中发现 miR-375 表达下调。miR-375 的过表达抑制了 LSCC 细胞的活力和迁移,并促进了细胞凋亡。Jefferson 数据库和双荧光素酶报告基因检测证实 miR-375 可直接靶向 CST1。CST1 的过表达可逆转 miR-375 过表达对 LSCC 细胞的抗癌作用。
研究结果表明,miR-375/CST1 轴参与了 LSCC 的进展。
3 级。